• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

费城染色体阴性慢性髓性白血病的分子与临床研究

Molecular and clinical investigations in Philadelphia chromosome-negative chronic myelogenous leukemia.

作者信息

Ohyashiki J H, Ohyashiki K, Ito H, Toyama K

机构信息

Department of Internal Medicine, Tokyo Medical College, Japan.

出版信息

Cancer Genet Cytogenet. 1988 Jul 1;33(1):119-26. doi: 10.1016/0165-4608(88)90057-x.

DOI:10.1016/0165-4608(88)90057-x
PMID:2838155
Abstract

We performed molecular studies in five cases of Philadelphia (Ph) translocation-negative chronic myelogenous leukemia (CML). Among the five, one case showed a 7q - anomaly; the remaining four had normal karyotypes. The 5' or 3' breakpoint cluster region (bcr) DNA probes detected rearrangements in two of the five cases. The two cases with bcr rearrangement showed clinical and hematologic manifestations similar to those with Ph-positive CML; for example, basophilia in the peripheral blood and marked hepatosplenomegaly. On the other hand, the three Ph-negative CML cases without bcr rearrangement manifested somewhat different clinical manifestation; that is, they did not respond to busulfan therapy in the chronic phase. Our observations suggest a heterogeneity in Ph-negative CML with at least two subtypes: one with a rearranged bcr gene showing clinical and hematologic features akin to those of CML with a Ph translocation, and the other without such a rearrangement and with a somewhat different clinical feature. Furthermore, the present data point to the possibility of the existence of Ph-negative CML without bcr rearrangement.

摘要

我们对5例费城(Ph)染色体易位阴性的慢性粒细胞白血病(CML)患者进行了分子研究。在这5例患者中,1例显示7号染色体长臂缺失异常;其余4例核型正常。5′或3′断裂点簇集区(bcr)DNA探针在5例中的2例检测到重排。这2例bcr重排的患者表现出与Ph阳性CML相似的临床和血液学表现;例如,外周血嗜碱性粒细胞增多和明显的肝脾肿大。另一方面,3例无bcr重排的Ph阴性CML患者表现出略有不同的临床表现;即,它们在慢性期对白消安治疗无反应。我们的观察结果提示Ph阴性CML存在异质性,至少有两种亚型:一种是bcr基因重排,表现出与Ph染色体易位的CML相似的临床和血液学特征,另一种无此类重排,临床特征略有不同。此外,目前的数据表明存在无bcr重排的Ph阴性CML的可能性。

相似文献

1
Molecular and clinical investigations in Philadelphia chromosome-negative chronic myelogenous leukemia.费城染色体阴性慢性髓性白血病的分子与临床研究
Cancer Genet Cytogenet. 1988 Jul 1;33(1):119-26. doi: 10.1016/0165-4608(88)90057-x.
2
Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy.伴有断裂点簇集区重排的费城阴性慢性粒细胞白血病:分子分析、临床特征及治疗反应
J Clin Oncol. 1988 Oct;6(10):1569-75. doi: 10.1200/JCO.1988.6.10.1569.
3
Significance and correlations of molecular analysis results in patients with Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia.费城染色体阴性慢性粒细胞白血病和慢性粒单核细胞白血病患者分子分析结果的意义及相关性
Am J Med. 1988 Nov;85(5):639-44. doi: 10.1016/s0002-9343(88)80235-3.
4
The correlation of breakpoint cluster region rearrangement and p210 phl/abl expression with morphological analysis of Ph-negative chronic myeloid leukemia and other myeloproliferative diseases.
Blood. 1988 Feb;71(2):349-55.
5
Utility of molecular genetic analysis of bcr rearrangement in the diagnosis of chronic myeloid leukemia.bcr重排的分子遗传学分析在慢性髓性白血病诊断中的应用
Cancer Genet Cytogenet. 1987 Nov;29(1):1-7. doi: 10.1016/0165-4608(87)90025-2.
6
Rearrangement of the bcr gene in Philadelphia chromosome-negative chronic myeloid leukemia.费城染色体阴性慢性髓性白血病中bcr基因的重排
Blood. 1986 Oct;68(4):957-60.
7
Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up results.伴有断裂点簇集区重排的费城染色体阴性慢性粒细胞白血病。长期随访结果。
Cancer. 1995 Jan 15;75(2):464-70. doi: 10.1002/1097-0142(19950115)75:2<464::aid-cncr2820750209>3.0.co;2-e.
8
Philadelphia-positive chronic myelogenous leukemia with breakpoint 5' of the breakpoint cluster region but within the bcr gene.
Blut. 1987 Dec;55(6):505-11. doi: 10.1007/BF00320220.
9
The genomic breakpoint in a patient with Philadelphia-positive acute leukemia is 5' of the breakpoint cluster region.
Cancer Genet Cytogenet. 1988 Jun;32(2):217-27. doi: 10.1016/0165-4608(88)90284-1.
10
Absence in Ph-negative, M-BCR rearrangement-positive chronic myelogenous leukemia of linkage between 5' ABL and 3' M-BCR sequences in Philadelphia translocation.Ph阴性、M-BCR重排阳性慢性髓性白血病中费城染色体易位时5'Abl与3'M-BCR序列之间连接的缺失
Leukemia. 1992 May;6(5):385-92.

引用本文的文献

1
Chronic Myeloid Leukemia, from Pathophysiology to Treatment-Free Remission: A Narrative Literature Review.慢性髓性白血病:从病理生理学到无治疗缓解——一篇叙述性文献综述
J Blood Med. 2023 Apr 6;14:261-277. doi: 10.2147/JBM.S382090. eCollection 2023.
2
Complex translocations, simple variant translocations and Ph-negative cases in chronic myelogenous leukaemia.
Hum Genet. 1990 Oct;85(6):565-8. doi: 10.1007/BF00193575.